← FDA Drug Approvals (Drugs@FDA)
LINACLOTIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2021-02-09
Drug application
- FDA Application #
ANDA209564- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINACLOTIDE
- Generic name
- Linaclotide
- Active ingredients
- LINACLOTIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2021-02-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown